Skip to content

Coronavirus infection in immunosuppressed children

Coronavirus infection in primary or secondary immunosuppressed children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN10175886
Enrollment
400
Registered
2020-07-14
Start date
2020-03-17
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (SARS-CoV-2 infection) Infections and Infestations COVID-19 (SARS-CoV-2 infection)

Interventions

Eligible patients will be identified by the team responsible for their clinical care. Patients and/or parents will be contacted NHS clinical methods with a weblink directing them to the study website.

Sponsors

University Hospital Southampton NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Parent of immunosuppressed patient aged <16 years or immunosuppressed patient aged 16-17 years 2. Family able to complete the questionnaire which will be in English (due to current resources available translation will not be possible) 3. Reliable access to the internet

Exclusion criteria

Exclusion criteria: Unable to understand English

Design outcomes

Primary

MeasureTime frame
COVID-19 infection in children/adults assessed by online questionnaire as frequency of: cough, fever, diarrhoea, shortness of breath, sore throat, blocked nose, red eyes, headache, joint pain, muscle pain, fatigue, chills, nausea, vomiting, over a year

Secondary

MeasureTime frame
Over the 1 year period: 1. Number of children/adults tested positive for COVID-19 measured using patient records 2. Patient/parent reported positive tests for COVID-19 measured using the online questionnaire 3. Number of children/adults admitted in hospital because of COVID-19 measured using patient records 4. Patient/parent reported admissions in hospital because of COVID-19 measured using the online questionnaire 5. To assess the impact of COVID-19 infection on the daily activities of immunosuppressed adults and children measured using patient records 6. Patient/parent reported effect of COVID-19 on daily activities measured using the online questionnaire

Countries

England, Scotland, United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026